AC093797.1 as a Potential Biomarker to Indicate the Prognosis of Hepatocellular Carcinoma and Inhibits Cell Proliferation, Invasion, and Migration by Reprogramming Cell Metabolism and Extracellular Matrix Dynamics

Purpose: The risk signature composed of four lncRNA (AC093797.1, POLR2J4, AL121748.1, and AL162231.4.) can be used to predict the overall survival (OS) of patients with hepatocellular carcinoma (HCC). However, the clinical significance and biological function of AC093797.1 are still unexplored in HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoling, Wang, Chenyu, Yang, Qing, Yuan, Yue, Sheng, Yunjian, Li, Decheng, Ojha, Suvash Chandra, Sun, Changfeng, Deng, Cunliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678093/
https://www.ncbi.nlm.nih.gov/pubmed/34925460
http://dx.doi.org/10.3389/fgene.2021.778742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678093/
https://www.ncbi.nlm.nih.gov/pubmed/34925460
http://dx.doi.org/10.3389/fgene.2021.778742

Ejemplares similares